{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:08:06Z","timestamp":1769854086588,"version":"3.49.0"},"reference-count":137,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-030831"],"award-info":[{"award-number":["POCI-01-0145-FEDER-030831"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BTM-TEC\/30831\/2017"],"award-info":[{"award-number":["PTDC\/BTM-TEC\/30831\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Despite the intensive efforts dedicated to cancer diagnosis and treatment, lung cancer (LCa) remains the leading cause of cancer-related mortality, worldwide. The poor survival rate among lung cancer patients commonly results from diagnosis at late-stage, limitations in characterizing tumor heterogeneity and the lack of non-invasive tools for detection of residual disease and early recurrence. Henceforth, research on liquid biopsies has been increasingly devoted to overcoming these major limitations and improving management of LCa patients. Liquid biopsy is an emerging field that has evolved significantly in recent years due its minimally invasive nature and potential to assess various disease biomarkers. Several strategies for characterization of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have been developed. With the aim of standardizing diagnostic and follow-up practices, microfluidic devices have been introduced to improve biomarkers isolation efficiency and specificity. Nonetheless, implementation of lab-on-a-chip platforms in clinical practice may face some challenges, considering its recent application to liquid biopsies. In this review, recent advances and strategies for the use of liquid biopsies in LCa management are discussed, focusing on high-throughput microfluidic devices applied for CTCs and ctDNA isolation and detection, current clinical validation studies and potential clinical utility.<\/jats:p>","DOI":"10.3390\/cancers13092101","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T02:31:43Z","timestamp":1619490703000},"page":"2101","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4837-6539","authenticated-orcid":false,"given":"\u00c2ngela","family":"Carvalho","sequence":"first","affiliation":[{"name":"i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal"},{"name":"INEB-Instituto de Engenharia Biom\u00e9dica, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal"},{"name":"Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"}]},{"given":"Gabriela","family":"Ferreira","sequence":"additional","affiliation":[{"name":"i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal"},{"name":"INEB-Instituto de Engenharia Biom\u00e9dica, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal"},{"name":"Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8968-6050","authenticated-orcid":false,"given":"Duarte","family":"Seixas","sequence":"additional","affiliation":[{"name":"i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal"},{"name":"INEB-Instituto de Engenharia Biom\u00e9dica, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal"},{"name":"Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"}]},{"given":"Catarina","family":"Guimar\u00e3es-Teixeira","sequence":"additional","affiliation":[{"name":"Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-4666","authenticated-orcid":false,"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[{"name":"Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-4605","authenticated-orcid":false,"given":"Fernando J.","family":"Monteiro","sequence":"additional","affiliation":[{"name":"i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal"},{"name":"INEB-Instituto de Engenharia Biom\u00e9dica, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal"},{"name":"Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Faculdade de Engenharia, Departamento de Engenharia Metal\u00fargica e Materiais, Universidade do Porto, Rua Dr Roberto Frias, s\/n, 4200-465 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5345","authenticated-orcid":false,"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[{"name":"Porto Comprehensive Cancer Center (P.CCC), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), R. Dr. Ant\u00f3nio Bernardino de Almeida, 4200-072 Porto, Portugal"},{"name":"Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin.","DOI":"10.3322\/caac.21660"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-019-0736-3","article-title":"Emerging therapies for small cell lung cancer","volume":"12","author":"Yang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: Current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2217\/lmt-2016-0008","article-title":"Lung cancer screening: Detected nodules, what next?","volume":"5","author":"Chen","year":"2016","journal-title":"Lung Cancer Manag."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.21037\/atm.2019.03.28","article-title":"Liquid biopsy for lung cancers: An update on recent developments","volume":"7","author":"Revelo","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00508-018-1317-0","article-title":"Complications of CT-guided transthoracic lung biopsy: A short report on current literature and a case of systemic air embolism","volume":"130","author":"Lang","year":"2018","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2017170347","article-title":"Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand\u20131 Expression for Immunotherapy in Non\u2013Small Cell Lung Cancer","volume":"287","author":"Tsai","year":"2018","journal-title":"Radiology"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rijavec, E., Coco, S., Genova, C., Grossi, F., and Longo, L. (2019). Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges. Cancers, 12.","DOI":"10.3390\/cancers12010017"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lim, M., Kim, C.-J., Sunkara, V., Kim, M.-H., and Cho, Y.-K. (2018). Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA). Micromachines, 9.","DOI":"10.3390\/mi9030100"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00595-018-1659-2","article-title":"A liquid biopsy in primary lung cancer","volume":"49","author":"Yoneda","year":"2019","journal-title":"Surg. Today"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1002\/cam4.2485","article-title":"Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment","volume":"8","author":"Su","year":"2019","journal-title":"Cancer Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jtho.2018.02.014","article-title":"Cell-Free Plasma DNA-Guided Treatment with Osimertinib in Patients with Advanced EGFR-Mutated NSCLC","volume":"13","author":"Buder","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sierra, J., Marrugo-Ram\u00edrez, J., Rodriguez-Trujillo, R., Mir, M., and Samitier, J. (2020). Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer. Sensors, 20.","DOI":"10.3390\/s20051317"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kulasinghe, A., Wu, H., Punyadeera, C., and Warkiani, M.E. (2018). The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy. Micromachines, 9.","DOI":"10.3390\/mi9080397"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"032902","DOI":"10.1063\/1.4948525","article-title":"Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine","volume":"10","author":"Wang","year":"2016","journal-title":"Biomicrofluidics"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Khoo, B.L., Warkiani, M.E., Tan, D.S.-W., Bhagat, A.A.S., Irwin, D., Lau, D.P., Lim, A.S.T., Lim, K.H., Krisna, S.S., and Lim, W.-T. (2014). Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099409"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fonc.2017.00193","article-title":"Lung cancer: Understanding its molecular pathology and the 2015 WHO classification","volume":"7","author":"Inamura","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.semcancer.2019.09.015","article-title":"Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer","volume":"61","author":"Harrison","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S1470-2045(16)30508-3","article-title":"Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): A multicentre, open-label, single-arm, phase 2 study","volume":"17","author":"Goss","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/2159-8290.CD-16-1123","article-title":"Targeting ALK: Precision Medicine Takes on Drug Resistance","volume":"7","author":"Lin","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_21","first-page":"3233","article-title":"Prognostic value of KRAS\/TP53\/PIK3CA in non\u2011small cell lung cancer","volume":"17","author":"Zhao","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pawelczyk, K., Piotrowska, A., Ciesielska, U., Jablonska, K., Glatzel-Plucinska, N., Grzegrzo\u0142ka, J., Podhorska-Oko\u0141\u00f3w, M., Dzi\u0119giel, P., and Nowinska, K. (2019). Role of PD-L1 expression in non-small cell lung cancer and their prognostic significance according to clinicopathological factors and diagnostic markers. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040824"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41598-018-36096-7","article-title":"PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-319-40389-2_14","article-title":"Small Cell Lung Cancer","volume":"170","author":"Bernhardt","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1038\/s41598-017-05562-z","article-title":"Small cell lung cancer: Model of circulating tumor cell tumorospheres in chemoresistance","volume":"7","author":"Klameth","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1158\/1078-0432.CCR-14-2958","article-title":"Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?","volume":"21","author":"Pietanza","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtho.2017.09.1951","article-title":"Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse","volume":"13","author":"Almodovar","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-019-0129-x","article-title":"Immunotherapy in extensive small cell lung cancer","volume":"8","author":"Verma","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.21037\/jtd.2020.01.37","article-title":"Immunotherapy for extensive stage small cell lung cancer","volume":"12","author":"Pacheco","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lungcan.2017.08.008","article-title":"Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy","volume":"112","author":"Aggarwal","year":"2017","journal-title":"Lung Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1158\/1078-0432.CCR-16-1231","article-title":"Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA","volume":"22","author":"Thompson","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/tlcr.2017.07.05","article-title":"The clinical utility of circulating tumour cells in patients with small cell lung cancer","volume":"6","author":"Foy","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"190052","DOI":"10.1183\/16000617.0052-2019","article-title":"Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages","volume":"29","author":"Guibert","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"041503","DOI":"10.1063\/1.5087690","article-title":"Recent advances in microfluidic methods in cancer liquid biopsy","volume":"13","author":"Iliescu","year":"2019","journal-title":"Biomicrofluidics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2011.10.018","article-title":"Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer","volume":"76","author":"Gray","year":"2012","journal-title":"Lung Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: An awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","article-title":"Systemic Spread Is an Early Step in Breast Cancer","volume":"13","author":"Geigl","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cell.2017.01.026","article-title":"SnapShot: Circulating Tumor Cells","volume":"168","author":"Dive","year":"2017","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11893","DOI":"10.1021\/acs.analchem.5b03484","article-title":"Label-Free Isolation and mRNA Detection of Circulating Tumor Cells from Patients with Metastatic Lung Cancer for Disease Diagnosis and Monitoring Therapeutic Efficacy","volume":"87","author":"Wang","year":"2015","journal-title":"Anal. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biomaterials.2015.03.004","article-title":"Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes","volume":"54","author":"Wang","year":"2015","journal-title":"Biomaterials"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/s41598-017-01150-3","article-title":"Microfluidic Isolation of Circulating Tumor Cell Clusters by Size and Asymmetry","volume":"7","author":"Au","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrclinonc.2013.253","article-title":"Molecular analysis of circulating tumour cells\u2014biology and biomarkers","volume":"11","author":"Krebs","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1158\/1078-0432.CCR-15-1416","article-title":"Enumeration and Molecular Characterization of Tumor Cells in Lung Cancer Patients Using a Novel In Vivo Device for Capturing Circulating Tumor Cells","volume":"22","author":"Gorges","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/onc.2015.192","article-title":"The biology of circulating tumor cells","volume":"35","author":"Pantel","year":"2016","journal-title":"Oncogene"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdx156","article-title":"A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups","volume":"28","author":"Lindsay","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/CBM-160090","article-title":"Clinical significance of circulating tumor cells in squamous cell lung cancer patients","volume":"18","author":"Qi","year":"2017","journal-title":"Cancer Biomark."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fonc.2018.00311","article-title":"The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer","volume":"8","author":"Kapeleris","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fonc.2014.00271","article-title":"A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer","volume":"4","author":"Huang","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/pcm.2019.11.07","article-title":"Circulating tumor cells: Moving forward into clinical applications","volume":"3","year":"2020","journal-title":"Precis. Cancer Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.critrevonc.2018.03.004","article-title":"Circulating tumor cells count as a predictor of survival in lung cancer","volume":"125","author":"Syrigos","year":"2018","journal-title":"Crit. Rev. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.21037\/tlcr.2017.07.03","article-title":"Biology and clinical significance of circulating tumor cell subpopulations in lung cancer","volume":"6","author":"Wikman","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100087","DOI":"10.1016\/j.bdq.2019.100087","article-title":"The emerging role of cell-free DNA as a molecular marker for cancer management","volume":"17","author":"Bronkhorst","year":"2019","journal-title":"Biomol. Detect. Quantif."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/2159-8290.CD-13-1014","article-title":"Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA","volume":"4","author":"Haber","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41416-020-01047-5","article-title":"Clinical relevance of blood-based ctDNA analysis: Mutation detection and beyond","volume":"124","author":"Keller","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"44583","DOI":"10.18632\/oncotarget.10069","article-title":"Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer","volume":"7","author":"Ai","year":"2016","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/bjc.2015.225","article-title":"Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease","volume":"113","author":"Szpechcinski","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.csbj.2018.10.002","article-title":"Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management","volume":"16","author":"Elazezy","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0009-8981(01)00665-9","article-title":"About the possible origin and mechanism of circulating DNA apoptosis and active DNA release","volume":"313","author":"Stroun","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"ref_63","first-page":"2623","article-title":"Cell-free DNA in the circulation as a potential cancer biomarker","volume":"31","author":"Kohler","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.2016.66.7162","article-title":"Association Between Plasma Genotyping and Outcomes of Treatment with Osimertinib (AZD9291) in Advanced Non\u2013Small-Cell Lung Cancer","volume":"34","author":"Oxnard","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Nunes, S.P., Diniz, F., Moreira-Barbosa, C., Const\u00e2ncio, V., Silva, A.V., Oliveira, J., Soares, M., Paulino, S., Cunha, A.L., and Rodrigues, J. (2019). Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091500"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13148-019-0779-x","article-title":"Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel","volume":"11","author":"Nunes","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Const\u00e2ncio, V., Nunes, S.P., Henrique, R., and Jer\u00f3nimo, C. (2020). DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types. Cells, 9.","DOI":"10.3390\/cells9030624"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Yousuff, C.M., Ho, E.T.W., Hussain, K.I., and Hamid, N.H.B. (2017). Microfluidic Platform for Cell Isolation and Manipulation Based on Cell Properties. Micromachines, 8.","DOI":"10.3390\/mi8010015"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"120701","DOI":"10.1063\/1.5072769","article-title":"Size- and deformability-based isolation of circulating tumor cells with microfluidic chips and their applications in clinical studies","volume":"8","author":"Chen","year":"2018","journal-title":"AIP Adv."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Lei, K.F. (2020). A Review on Microdevices for Isolating Circulating Tumor Cells. Micromachines, 11.","DOI":"10.3390\/mi11050531"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.20892\/j.issn.2095-3941.2018.0256","article-title":"Advances in isolation and detection of circulating tumor cells based on microfluidics","volume":"15","author":"Dan","year":"2018","journal-title":"Cancer Biol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Rushton, A., Nteliopoulos, G., Shaw, J., and Coombes, R. (2021). A Review of Circulating Tumour Cell Enrichment Technologies. Cancers, 13.","DOI":"10.3390\/cancers13050970"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1039\/D0AN01148G","article-title":"Microfluidics for label-free sorting of rare circulating tumor cells","volume":"145","author":"Zhu","year":"2020","journal-title":"Analyst"},{"key":"ref_74","first-page":"1235","article-title":"Isolation of rare circulating tumour cells in cancer patients by microchip technology","volume":"450","author":"Nagrath","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMoa0800668","article-title":"Detection of Mutations inEGFRin Circulating Lung-Cancer Cells","volume":"359","author":"Maheswaran","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2018.03.006","article-title":"NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells","volume":"125","author":"Jan","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1700701","DOI":"10.1002\/adhm.201700701","article-title":"Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection","volume":"7","author":"Shen","year":"2017","journal-title":"Adv. Health Mater."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1158\/0008-5472.CAN-13-1541","article-title":"CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist","volume":"74","author":"Sarvi","year":"2014","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12307-014-0164-4","article-title":"Circulating Tumor Cells: Who is the Killer?","volume":"7","year":"2014","journal-title":"Cancer Microenviron."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1038\/s41598-017-04033-9","article-title":"Optofluidic device for the quantification of circulating tumor cells in breast cancer","volume":"7","author":"Pedrol","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1039\/C6BM00933F","article-title":"Hyaluronic acid-functionalized electrospun PLGA nanofibers embedded in a microfluidic chip for cancer cell capture and culture","volume":"5","author":"Xu","year":"2017","journal-title":"Biomater. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1039\/C6LC01179A","article-title":"Dual-patterned immunofiltration (DIF) device for the rapid efficient negative selection of heterogeneous circulating tumor cells","volume":"16","author":"Bu","year":"2016","journal-title":"Lab Chip"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1039\/C3LC50625H","article-title":"Technologies for label-free separation of circulating tumor cells: From historical foundations to recent developments","volume":"14","author":"Jin","year":"2014","journal-title":"Lab Chip"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1002\/smll.201601394","article-title":"Affinity Versus Label-Free Isolation of Circulating Tumor Cells: Who Wins?","volume":"12","author":"Murlidhar","year":"2016","journal-title":"Small"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.18632\/oncotarget.7220","article-title":"Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology","volume":"7","author":"Che","year":"2016","journal-title":"Oncotarget"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"011803","DOI":"10.1063\/1.4774312","article-title":"Separation of tumor cells with dielectrophoresis-based microfluidic chip","volume":"7","author":"Alshareef","year":"2013","journal-title":"Biomicrofluidics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/smll.201502808","article-title":"Nanoelectromechanical Chip (NELMEC) Combination of Nanoelectronics and Microfluidics to Diagnose Epithelial and Mesenchymal Circulating Tumor Cells from Leukocytes","volume":"12","author":"Hosseini","year":"2016","journal-title":"Small"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"061501","DOI":"10.1063\/1.5125264","article-title":"Spiral microfluidic devices for cell separation and sorting in bioprocesses","volume":"13","author":"Herrmann","year":"2019","journal-title":"Biomicrofluidics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1504484112","article-title":"Acoustic separation of circulating tumor cells","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1002\/cam4.3077","article-title":"Magnetically driven microfluidics for isolation of circulating tumor cells","volume":"9","author":"Luo","year":"2020","journal-title":"Cancer Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/cancers6010545","article-title":"Isolation of Circulating Tumor Cells by Dielectrophoresis","volume":"6","author":"Gascoyne","year":"2014","journal-title":"Cancers"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"239362","DOI":"10.1155\/2015\/239362","article-title":"Benchtop Technologies for Circulating Tumor Cells Separation Based on Biophysical Properties","volume":"2015","author":"Low","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1039\/C5LC00226E","article-title":"Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps","volume":"15","author":"Qin","year":"2015","journal-title":"Lab Chip"},{"key":"ref_94","first-page":"1","article-title":"Technologies for circulating tumor cell separation from whole blood","volume":"12","author":"Lee","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/elps.201600386","article-title":"Hybrid microfluidics combined with active and passive approaches for continuous cell separation","volume":"38","author":"Yan","year":"2017","journal-title":"Electrophoresis"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.snb.2016.05.163","article-title":"An integrated microfluidic chip for one-step isolation of circulating tumor cells","volume":"238","author":"Lee","year":"2017","journal-title":"Sens. Actuators B Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1039\/c0lc00345j","article-title":"Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP)","volume":"11","author":"Moon","year":"2011","journal-title":"Lab Chip"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"034114","DOI":"10.1063\/1.4812688","article-title":"Highly selective biomechanical separation of cancer cells from leukocytes using microfluidic ratchets and hydrodynamic concentrator","volume":"7","author":"Lin","year":"2013","journal-title":"Biomicrofluidics"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nprot.2014.044","article-title":"Microfluidic, marker-free isolation of circulating tumor cells from blood samples","volume":"9","author":"Karabacak","year":"2014","journal-title":"Nat. Protoc."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.5306\/wjco.v11.i9.723","article-title":"Circulating tumor DNA: Where are we now? A mini review of the literature","volume":"11","author":"Fortuna","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Tang, H., Yu, Q., Qian, X., Ni, K., and Wang, X. (2018). Fabricating and Characterizing the Microfluidic Solid Phase Extraction Module Coupling with Integrated ESI Emitters. Micromachines, 9.","DOI":"10.3390\/mi9050212"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Xu, Y., Zhang, Z., Su, Z., Zhou, X., Han, X., and Liu, Q. (2020). Continuous Microfluidic Purification of DNA Using Magnetophoresis. Micromachines, 11.","DOI":"10.3390\/mi11020187"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fsigen.2009.02.010","article-title":"An integrated microfluidic device for DNA purification and PCR amplification of STR fragments","volume":"4","author":"Bienvenue","year":"2010","journal-title":"Forensic Sci. Int. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Xu, Z., Qiao, Y., and Tu, J. (2019). Microfluidic Technologies for cfDNA Isolation and Analysis. Micromachines, 10.","DOI":"10.3390\/mi10100672"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1021\/ac060390t","article-title":"Microchip-Based Macroporous Silica Sol\u2212Gel Monolith for Efficient Isolation of DNA from Clinical Samples","volume":"78","author":"Wu","year":"2006","journal-title":"Anal. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1800614","DOI":"10.1002\/advs.201800614","article-title":"Simple and Low-Cost Sampling of Cell-Free Nucleic Acids from Blood Plasma for Rapid and Sensitive Detection of Circulating Tumor DNA","volume":"5","author":"Jin","year":"2018","journal-title":"Adv. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1039\/C8LC00716K","article-title":"Microfluidic-based solid phase extraction of cell free DNA","volume":"18","author":"Campos","year":"2018","journal-title":"Lab Chip"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10404-011-0782-9","article-title":"A magnetic bead-based DNA extraction and purification microfluidic device","volume":"11","author":"Azimi","year":"2011","journal-title":"Microfluid. Nanofluidics"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"033012","DOI":"10.1088\/1742-6596\/1400\/3\/033012","article-title":"Magnetic beads-based nucleic acids extraction in microfluidic chip","volume":"1400","author":"Afonicheva","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Oberacker, P., Stepper, P., Bond, D.M., H\u00f6hn, S., Focken, J., Meyer, V., Schelle, L., Sugrue, V.J., Jeunen, G.-J., and Moser, T. (2019). Bio-On-Magnetic-Beads (BOMB): Open platform for high-throughput nucleic acid extraction and manipulation. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000107"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"9306564","DOI":"10.1155\/2017\/9306564","article-title":"Current Nucleic Acid Extraction Methods and Their Implications to Point-of-Care Diagnostics","volume":"2017","author":"Ali","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/ac3026509","article-title":"A Microfluidic Liquid Phase Nucleic Acid Purification Chip to Selectively Isolate DNA or RNA from Low Copy\/Single Bacterial Cells in Minute Sample Volume Followed by Direct On-Chip Quantitative PCR Assay","volume":"85","author":"Zhang","year":"2013","journal-title":"Anal. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.chroma.2007.11.119","article-title":"Electrophoretic separations on microfluidic chips","volume":"1184","author":"Wu","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Zhang, H., Chang, H., and Neuzil, P. (2019). DEP-on-a-Chip: Dielectrophoresis Applied to Microfluidic Platforms. Micromachines, 10.","DOI":"10.3390\/mi10060423"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/ijh-2015-0009","article-title":"Dielectrophoretic recovery of DNA from plasma for the identification of chronic lymphocytic leukemia point mutations","volume":"5","author":"Manouchehri","year":"2016","journal-title":"Int. J. Hematol. Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41698-019-0107-0","article-title":"Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics","volume":"4","author":"Lee","year":"2020","journal-title":"NPJ Precis. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.dld.2015.05.023","article-title":"Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer","volume":"47","author":"Sefrioui","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"eaat6459","DOI":"10.1126\/sciadv.aat6459","article-title":"Facile profiling of molecular heterogeneity by microfluidic digital melt","volume":"4","author":"Pisanic","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1039\/C8LC01189C","article-title":"Multilayer microfluidic array for highly efficient sample loading and digital melt analysis of DNA methylation","volume":"19","author":"Giammanco","year":"2019","journal-title":"Lab Chip"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1039\/C9LC00400A","article-title":"Clinical translation of microfluidic sensor devices: Focus on calibration and analytical robustness","volume":"19","author":"Gowers","year":"2019","journal-title":"Lab Chip"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1039\/D0LC00577K","article-title":"Recent advances in microfluidic technologies for circulating tumor cells: Enrichment, single-cell analysis, and liquid biopsy for clinical applications","volume":"20","author":"Pei","year":"2020","journal-title":"Lab Chip"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"12322","DOI":"10.1021\/acs.analchem.0c01970","article-title":"3D Printed Microfluidic Devices for Solid-Phase Extraction and On-Chip Fluorescent Labeling of Preterm Birth Risk Biomarkers","volume":"92","author":"Bickham","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Coelho, B., Veigas, B., Fortunato, E., Martins, R., \u00c1guas, H., Igreja, R., and Baptista, P.V. (2017). Digital Microfluidics for Nucleic Acid Amplification. Sensors, 17.","DOI":"10.3390\/s17071495"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"045022","DOI":"10.1063\/1.5137784","article-title":"Microfluidic chip for multiple detection of miRNA biomarkers in breast cancer based on three-segment hybridization","volume":"10","author":"Gao","year":"2020","journal-title":"AIP Adv."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.2010.28.7045","article-title":"Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients with Non\u2013Small-Cell Lung Cancer","volume":"29","author":"Krebs","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/JTO.0b013e31823c5c16","article-title":"Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches","volume":"7","author":"Krebs","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1039\/C5AN02156A","article-title":"Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer","volume":"141","author":"Chudziak","year":"2016","journal-title":"Analyst"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Janning, M., Kobus, F., Babayan, A., Wikman, H., Velthaus, J.-L., Bergmann, S., Schatz, S., Falk, M., Berger, L.-A., and B\u00f6ttcher, L.-M. (2019). Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1\/PD-L1 Inhibitors. Cancers, 11.","DOI":"10.3390\/cancers11060835"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41378-019-0045-6","article-title":"Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel","volume":"5","author":"Zhou","year":"2019","journal-title":"Microsystems Nanoeng."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/cyto.a.23902","article-title":"An Integrated Microfluidic Chip and Its Clinical Application for Circulating Tumor Cell Isolation and Single-Cell Analysis","volume":"97","author":"Xu","year":"2020","journal-title":"Cytom. Part A"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/1078-0432.CCR-15-1031","article-title":"Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses","volume":"22","author":"Sundaresan","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3343\/alm.2019.39.5.478","article-title":"Comparison of cobas EGFR Mutation Test v2 and PANAMutyper-R-EGFR for Detection and Semi-Quantification of Epidermal Growth Factor Receptor Mutations in Plasma and Pleural Effusion Supernatant","volume":"39","author":"Han","year":"2019","journal-title":"Ann. Lab. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jtho.2016.05.036","article-title":"ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study","volume":"11","author":"Reck","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1038\/s41598-017-02217-x","article-title":"Droplet Digital PCR versus qPCR for gene expression analysis with low abundant targets: From variable nonsense to publication quality data","volume":"7","author":"Taylor","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"20913","DOI":"10.1038\/srep20913","article-title":"Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40880-018-0303-2","article-title":"Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: A prospective observational study","volume":"38","author":"Zhang","year":"2018","journal-title":"Cancer Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1039\/C8LC00165K","article-title":"Fully automated, on-site isolation of cfDNA from whole blood for cancer therapy monitoring","volume":"18","author":"Kim","year":"2018","journal-title":"Lab Chip"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/9\/2101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:53:09Z","timestamp":1760161989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/9\/2101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":137,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["cancers13092101"],"URL":"https:\/\/doi.org\/10.3390\/cancers13092101","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]}}}